Vor Biopharma Inc.
VOR
$0.59
-$0.044-6.94%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.95% | -7.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.81% | -1.80% | |||
| Operating Income | -9.81% | 1.80% | |||
| Income Before Tax | -11.44% | 1.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.44% | 1.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.44% | 1.01% | |||
| EBIT | -9.81% | 1.80% | |||
| EBITDA | -10.06% | 1.79% | |||
| EPS Basic | -8.97% | 1.25% | |||
| Normalized Basic EPS | -8.94% | 1.26% | |||
| EPS Diluted | -8.97% | 1.25% | |||
| Normalized Diluted EPS | -8.94% | 1.26% | |||
| Average Basic Shares Outstanding | 2.28% | 0.24% | |||
| Average Diluted Shares Outstanding | 2.28% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
